|
|
|
Insider
Information: |
Thomas James E |
Relationship: |
10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
2,692 |
|
Indirect Shares
|
3,644,468 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$3,932,250 |
|
|
Total
Shares |
3,647,160 |
|
|
Total
Value |
$3,932,250 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Coley Pharmaceutical Group, Inc. |
COLY |
Director |
2007-05-11 |
2,692 |
2007-05-11 |
2,035,940 |
Premium* |
|
CAS Medical Systems Inc |
CASM |
Director, 10% Owner |
2019-04-18 |
0 |
2018-12-13 |
1,605,000 |
Premium* |
|
Clarus Therapeutics Inc |
CRXT |
10% Owner |
2022-04-20 |
0 |
2022-04-20 |
3,528 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
COLY |
Coley Pharmaceutical Grou... |
Director |
|
2005-08-15 |
4 |
A |
$0.00 |
$0 |
I/I |
2,879,620 |
2,879,620 |
|
- |
|
COLY |
Coley Pharmaceutical Grou... |
Director |
|
2006-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,692 |
2,410,830 |
|
- |
|
COLY |
Coley Pharmaceutical Grou... |
Director |
|
2006-05-18 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,003,680) |
2,408,138 |
|
- |
|
CASM |
CAS Medical Systems Inc |
Director |
|
2011-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
3,953 |
3,953 |
0 |
- |
|
CASM |
CAS Medical Systems Inc |
Director |
|
2012-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,714 |
9,667 |
0 |
- |
|
CASM |
CAS Medical Systems Inc |
Director |
|
2013-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
6,211 |
15,878 |
0 |
- |
|
CASM |
CAS Medical Systems Inc |
Director |
|
2014-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
5,076 |
20,954 |
0 |
- |
|
CASM |
CAS Medical Systems Inc |
Director |
|
2017-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
33,454 |
0 |
- |
|
CASM |
CAS Medical Systems Inc |
Director |
|
2018-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
63,454 |
0 |
- |
|
CASM |
CAS Medical Systems Inc |
Director |
|
2015-02-11 |
4 |
B |
$1.30 |
$2,086,500 |
I/I |
1,605,000 |
5,938 |
2.25 |
- |
|
CASM |
CAS Medical Systems Inc |
Director |
|
2019-04-18 |
4 |
D |
$2.45 |
$155,462 |
D/D |
(63,454) |
0 |
0 |
- |
|
CRXT |
Clarus Therapeutics Inc |
10% Owner |
|
2022-04-20 |
4 |
S |
$2.53 |
$9,494,867 |
I/I |
(3,752,912) |
3,528 |
0 |
- |
|
COLY |
Coley Pharmaceutical Grou... |
Director |
|
2007-05-11 |
4 |
B |
$8.66 |
$519,600 |
I/I |
60,000 |
2,035,940 |
2.1 |
- |
|
COLY |
Coley Pharmaceutical Grou... |
Director |
|
2007-05-10 |
4 |
B |
$8.68 |
$868,000 |
I/I |
100,000 |
1,975,940 |
2.1 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|